Comprehensive HIV and Harm Prevention Via Telehealth
Recruiting · NCT05897099 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Miami
View the official record on ClinicalTrials.gov →Interventions studied
Comprehensive Tele-harm ReductionOff-site Linkage to HIV Prevention
What this trial is about
The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- age 18 or older
- able to speak English or Spanish
- willing and able to sign informed consent, provide locator information and medical records release
- non-reactive result on rapid HIV test
- use of SSP to exchange syringes 2 times in the past 3 months
- planning to stay in the area for 12 months
Exclusion criteria
- reactive HIV test
- currently on medications for opioid use disorder (MOUD) by urine drug screen
- currently on PrEP by self-report
- Principal or site investigator discretion
- currently in prison or jail
- current enrollment in Clinical Trials Network 121
- receipt of tele-harm reduction in previous 3 months
- signs or symptoms of acute HIV infection
Where it is running
2 locations listed across 1 US state.
- IDEA Miami - Miami, Florida, United States
- IDEA Syringe Services Program - Miami, Florida, United States